User menu

Costs and Benefits Associated With Diabetes Education: A Review of the Literature

Bibliographic reference Philippe, Marianne ; Opsomer, Reinier-Jacques ; Buysschaert, Martin ; Reynaert, Christine ; Jamart, Jacques ; et. al. Costs and Benefits Associated With Diabetes Education: A Review of the Literature.In: Diabetes & Metabolism, Vol. 35, p. A72-A72 (2009)
Permanent URL
  1. Bending the curve: options for achieving savings and improving value in U.S. health spending (2007)
  2. Chronic conditions: making the case for ongoing care (2007)
  3. Fonseca V. A., Diabetes Care: Moving (a Little) in the Winds of Change, 10.2337/dc07-2052
  4. An unhealthy America: the economic burden of chronic disease-charting a new course to save lives and increase productivity and economic growth (2007)
  5. About diabetes education (2008)
  6. Am J Prev Med., 22, 15 (2002)
  7. Norris S. L., Lau J., Smith S. J., Schmid C. H., Engelgau M. M., Self-Management Education for Adults With Type 2 Diabetes: A meta-analysis of the effect on glycemic control, 10.2337/diacare.25.7.1159
  8. Ansell Benjamin J., Not Getting to Goal: The Clinical Costs of Noncompliance, 10.18553/jmcp.2008.14.s6-b.9
  9. Gary Tiffany L., Genkinger Jeanine M., Guallar Eliseo, Peyrot Mark, Brancati Frederick L., Meta-Analysis of Randomized Educational and Behavioral Interventions in Type 2 Diabetes, 10.1177/014572170302900313
  10. Balamurugan Appathurai, Ohsfeldt Robert, Hughes Tom, Phillips Martha, Diabetes Self-management Education Program for Medicaid Recipients, 10.1177/0145721706294787
  11. Manag Care, 11, 45 (2002)
  12. Burton Wayne N., Connerty Catherine M., Evaluation of a Worksite-Based Patient Education Intervention Targeted at Employees With Diabetes Mellitus : , 10.1097/00043764-199808000-00007
  13. Chase H. P., Pearson J. A., Wightman C., Roberts M. D., Oderberg A. D., Garg S. K., Modem Transmission of Glucose Values Reduces the Costs and Need for Clinic Visits, 10.2337/diacare.26.5.1475
  14. Christensen N. K., Williams P., Pfister R., Cost Savings and Clinical Effectiveness of an Extension Service Diabetes Program, 10.2337/diaspect.17.3.171
  15. JAm Pharm Assoc, 43, 173 (2003)
  16. Weerdt I., Visser A. P., Kok G. J., Weerdt O., Veen E. A., Randomized Controlled Multicentre Evaluation of an Education Programme for Insulin-treated Diabetic Patients: Effects on Metabolic Control, Quality of Life, and Costs of Therapy, 10.1111/j.1464-5491.1991.tb01607.x
  17. Eddy David M., Schlessinger Leonard, Kahn Richard, Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes, 10.7326/0003-4819-143-4-200508160-00006
  18. West J Med, 169, 201 (1998)
  19. Garrett Daniel G., Bluml Benjamin M., Patient Self-Management Program for Diabetes: First-Year Clinical, Humanistic, and Economic Outcomes, 10.1331/1544345053623492
  20. Gilmer T. P., O'Connor P. J., Manning W. G., Rush W. A., The Cost to Health Plans of Poor Glycemic Control, 10.2337/diacare.20.12.1847
  21. , Costs Associated With the Primary Prevention of Type 2 Diabetes Mellitus in the Diabetes Prevention Program, 10.2337/diacare.26.1.36
  22. , Within-Trial Cost-Effectiveness of Lifestyle Intervention or Metformin for the Primary Prevention of Type 2 Diabetes, 10.2337/diacare.26.9.2518
  23. Katon W., Unutzer J., Fan M.-Y., Williams J. W., Schoenbaum M., Lin E. H.B., Hunkeler E. M., Cost-Effectiveness and Net Benefit of Enhanced Treatment of Depression for Older Adults With Diabetes and Depression, 10.2337/diacare.29.02.06.dc05-1572
  24. Keers J. C., Groen H., Sluiter W. J., Bouma J., Links T. P., Cost and benefits of a multidisciplinary intensive diabetes education programme, 10.1111/j.1365-2753.2005.00536.x
  25. Klonoff D. C., Schwartz D. M., An economic analysis of interventions for diabetes, 10.2337/diacare.23.3.390
  26. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin, 10.1056/nejmoa012512
  27. Menzin J., Langley-Hawthorne C., Friedman M., Boulanger L., Cavanaugh R., Potential Short-Term Economic Benefits of Improved Glycemic Control: A managed care perspective, 10.2337/diacare.24.1.51
  28. Ragucci Kelly R., Fermo Joli D., Wessell Andrea M., Chumney Elinor C., Effectiveness of Pharmacist-Administered Diabetes Mellitus Education and Management Services, 10.1592/phco.2005.25.12.1809
  29. J Manag Care Pharm, 9, 309 (2003)
  30. J Clin Endocrinol Metab, 83, 2635 (1998)
  31. J Manag Care Pharm, 11, 559 (2005)
  32. Sidorov J., Shull R., Tomcavage J., Girolami S., Lawton N., Harris R., Does Diabetes Disease Management Save Money and Improve Outcomes? : A report of simultaneous short-term savings and quality improvement associated with a health maintenance organization-sponsored disease management program among patients fulfilling health employer data and information set criteria, 10.2337/diacare.25.4.684
  33. JAMA, 280, 1490 (1998)
  34. Wagner Edward H., Effect of Improved Glycemic Control on Health Care Costs and Utilization, 10.1001/jama.285.2.182
  35. The CDC Diabetes Cost-effectiveness Group, Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes, 10.1001/jama.287.19.2542
  36. Ozminkowski Ronald J., Goetzel Ron Z., Smith Mark W., Cantor Richard I., Shaughnessy Anita, Harrison Mary, The Impact of the Citibank, NA, Health Management Program on Changes in Employee Health Risks Over Time : , 10.1097/00043764-200005000-00008
  37. Aldana Steven G., Financial Impact of Health Promotion Programs: A Comprehensive Review of the Literature, 10.4278/0890-1171-15.5.296
  38. Federal Register, Part II; 42 CFR Parts 410, 414, 424, 480 and 498 (2000)